Cancer risk in adult congenital heart disease
- PMID: 39711810
- PMCID: PMC11657617
- DOI: 10.1016/j.ijcchd.2023.100441
Cancer risk in adult congenital heart disease
Abstract
Advances in diagnostics and interventional/surgical treatment of patients with congenital heart disease (CHD) over the past several decades, allows a decline in rates of all-cause mortality, with a significant reduction in proportion of infant and childhood deaths with severe forms of CHD. However, the risk of premature death in adults with complex CHD remains elevated. A growing body of evidence has recently described the impact of non-cardiovascular comorbidities such as cancers, on morbidity, health care utilizations and mortality in adult patients with CHD. Aim of this review is to provide an appraisal of the current evidence that report associations between CHD and increased cancer risk in children and adults, and provide an overview of the specific risk factors.
Keywords: Cancer risk; Congenital heart disease; Genetics; Imaging; Radiation dose.
© 2023 The Authors.
Similar articles
-
Global, regional, and national time trends in mortality for congenital heart disease, 1990-2019: An age-period-cohort analysis for the Global Burden of Disease 2019 study.EClinicalMedicine. 2022 Jan 11;43:101249. doi: 10.1016/j.eclinm.2021.101249. eCollection 2022 Jan. EClinicalMedicine. 2022. PMID: 35059612 Free PMC article.
-
Position paper concerning the competence, performance and environment required for the practice of ablation in children and in congenital heart disease.Arch Cardiovasc Dis. 2020 Aug-Sep;113(8-9):492-502. doi: 10.1016/j.acvd.2020.02.002. Epub 2020 May 24. Arch Cardiovasc Dis. 2020. PMID: 32461091 Review.
-
Changing mortality in congenital heart disease.J Am Coll Cardiol. 2010 Sep 28;56(14):1149-57. doi: 10.1016/j.jacc.2010.03.085. J Am Coll Cardiol. 2010. PMID: 20863956
-
Racial/ethnic disparities in mortality related to congenital heart defects among children and adults in the United States.Ethn Dis. 2008 Autumn;18(4):442-9. Ethn Dis. 2008. PMID: 19157248
-
The Role of Epigenetics in Congenital Heart Disease.Genes (Basel). 2021 Mar 9;12(3):390. doi: 10.3390/genes12030390. Genes (Basel). 2021. PMID: 33803261 Free PMC article. Review.
Cited by
-
Congenital Heart Disease After Mid-Age: From the "Grown-Up" to the Elderly.Diagnostics (Basel). 2025 Feb 17;15(4):481. doi: 10.3390/diagnostics15040481. Diagnostics (Basel). 2025. PMID: 40002632 Free PMC article. Review.
References
-
- Khairy P., Ionescu-Ittu R., Mackie A.S., Abrahamowicz M., Pilote L., Marelli A.J. Changing mortality in congenital heart disease. J Am Coll Cardiol. 2010;56:1149–1157. - PubMed
-
- Greutmann M., Tobler D. Changing epidemiology and mortality in adult congenital heart disease: looking into the future. Future Cardiol. 2012;8:171–177. - PubMed
-
- Cohen S., Gurvitz M.Z., Beauséjour-Ladouceur V., Lawler P.R., Therrien J., Marelli A.J. Cancer risk in congenital heart disease-what is the evidence? Can J Cardiol. 2019;35:1750–1761. - PubMed
-
- Mandalenakis Z., Karazisi C., Skoglund K., et al. Risk of cancer among children and young adults with congenital heart disease compared with healthy controls. JAMA Netw Open. 2019;2 - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous